Article
Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian population samples.
Pathology oncology research : POR - 1 Jul 2014
Varszegi Dalma, Duga Balazs, Melegh Bela I, Sumegi Katalin, Kisfali Peter, Maasz Anita, Melegh Bela
Abstract excerpt
Patients treated successfully for pediatric Hodgkin's lymphoma are known to develop secondary malignancies; care is already taken in treatment to prevent this adverse effect. Recent GWAS study identified rs4946728 and rs1040411 noncoding SNPs located between PRDM1 and ATG1 genes on chromosome 6q21 as risk factors for secondary malignancies in patients formerly treated with radiotherapy for pediatric Hodgkin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
